Gyeonggi-do, South Korea

Ji-Yeon Park

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Paju-si, KR (2020 - 2021)
  • Gyeonggi-do, KR (2022)
  • Jeollanam-do, KR (2022)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Ji-Yeon Park: Innovator in Protein Kinase Inhibitors**

Introduction

Ji-Yeon Park, a prominent inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceutical innovations. With a total of three patents to his name, Park is focused on developing compounds that have the potential to revolutionize treatments for various protein kinase-related diseases including cancers and autoimmune disorders.

Latest Patents

Ji-Yeon Park's latest patents include a novel compound functioning as a protein kinase inhibitor, alongside a pharmaceutical composition. This invention presents a unique compound that not only exhibits protein kinase inhibitory activity but also includes stereoisomers and pharmaceutically acceptable salts. Such compounds are envisioned to be effective in preventing or treating protein kinase-related diseases such as cancers, autoimmune diseases, neurological disorders, metabolic issues, and infections. Another noteworthy patent is a heterocyclic compound serving as a protein kinase inhibitor, which shares similar therapeutic prospects, showcasing the versatility and efficacy of his innovative approaches.

Career Highlights

Throughout his career, Ji-Yeon Park has held positions at notable companies, including Hk Inno.N Corporation and Samsung Electronics Co., Ltd. His experience in these esteemed organizations has undoubtedly contributed to his expertise and ability to push the boundaries of pharmaceutical research.

Collaborations

In his journey of innovation, Ji-Yeon Park has collaborated with notable coworkers, such as Seung Chan Kim and So Young Ki. These partnerships reflect the importance of teamwork in the development of cutting-edge inventions and highlight the collaborative spirit that drives progress in research environments.

Conclusion

Ji-Yeon Park stands out as a dedicated inventor whose work in protein kinase inhibitors holds promise for the treatment of various challenging diseases. With his innovative spirit and commitment to research, he continues to contribute significantly to the pharmaceutical industry, paving the way for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…